SCM
Sarissa Capital Management Portfolio holdings
AUM
$154M
This Quarter Return
+4.37%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$352M
AUM Growth
+$352M
(-22%)
Cap. Flow
-$117M
Cap. Flow
% of AUM
-33.09%
Top 10 Holdings %
Top 10 Hldgs %
95.26%
Holding
18
New
2
Increased
4
Reduced
3
Closed
2
Top Buys
| 1 |
Perrigo
PRGO
|
$9.07M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
$5.07M |
| 3 |
ADXS
Advaxis, Inc.
ADXS
|
$4.85M |
| 4 |
Pacira BioSciences
PCRX
|
$4.07M |
| 5 |
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
|
$805K |
Top Sells
| 1 |
AbbVie
ABBV
|
$94.7M |
| 2 |
Quest Diagnostics
DGX
|
$33.9M |
| 3 |
Esperion Therapeutics
ESPR
|
$10.7M |
| 4 |
RPRX
Repros Therapeutics Inc.
RPRX
|
$970K |
| 5 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
$302K |
Sector Composition
| 1 | Healthcare | 78.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARIA
1
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $95M | 26.95% | 12,850,000 | – | – |
|
2
Biogen
BIIB
$19.4B
| $75M | 21.28% | 310,000 | – | – |
|
|
MDCO
3
DELISTED
Medicines Co
MDCO
| $58.9M | 16.72% | 1,752,000 | – | – |
|
|
ITCI
4
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $26.2M | 7.44% | 675,000 | – | – |
|
|
5
Pacira BioSciences
PCRX
$1.2B
| $22M | 6.25% | 653,000 +120,800 | +23% | +$4.07M |
|
|
RPTP
6
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $15.4M | 4.38% | 2,875,000 +150,000 | +6% | +$805K |
|
|
ARRY
7
DELISTED
Array Biopharma Inc
ARRY
| $15.3M | 4.35% | 4,300,000 +1,425,000 | +50% | +$5.07M |
|
|
8
Quest Diagnostics
DGX
$20.3B
| $12.9M | 3.67% | 159,000 -416,000 | -72% | -$33.9M |
|
|
9
Perrigo
PRGO
$3.27B
| $9.07M | 2.57% | +100,000 | New | +$9.07M |
|
|
SEEL
10
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $5.78M | 1.64% | 14,479,052 | – | – |
|
|
ADXS
11
DELISTED
Advaxis, Inc.
ADXS
| $4.85M | 1.38% | +600,000 | New | +$4.85M |
|
|
AEGR
12
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $3.95M | 1.12% | 2,649,000 +69,000 | +3% | +$103K |
|
|
13
AbbVie
ABBV
$372B
| $3.1M | 0.88% | 50,000 -1,530,000 | -97% | -$94.7M |
|
|
VVUS
14
DELISTED
Vivus Inc
VVUS
| $2.88M | 0.82% | 2,573,943 | – | – |
|
|
AVEO
15
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $1.92M | 0.55% | 2,000,000 -313,759 | -14% | -$302K |
|
|
16
Esperion Therapeutics
ESPR
$448M
| – | – | -633,000 | Closed | -$10.7M |
|
|
RPRX
17
DELISTED
Repros Therapeutics Inc.
RPRX
| – | – | -1,001,000 | Closed | -$970K |
|